Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and painful condition
in patients who have received chemotherapy. The role of neuromodulation therapy in …

Purpose The aim in this review was to explore recent advances in chemotherapy-induced
peripheral neuropathy (CIPN) management interventions and to identify the implications for …

Abstract Purpose of Review Chemotherapy-induced peripheral neuropathy (CIPN) is a
debilitating and often painful condition that occurs after administration of chemotherapeutic …

Purpose: Treatment of chemotherapy-induced peripheral neuropathy (CIPN) is challenging
for clinicians, and many clinical trials and meta-analyses on CIPN are controversial. There …

Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is one of the prevalent
and disabling side effects of cancer treatment. However, management strategies for CIPN …

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a commonly
encountered disease entity following chemotherapy for cancer treatment. Although only …

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common and
debilitating side effect of cancer treatment with no effective preventative strategy or definitive …

Purpose This systematic review was conducted to evaluate the best available evidence
regarding the use of non-invasive neuromodulation techniques for managing chemotherapy …

Background: Most individuals affected by cancer who are treated with certain
chemotherapies suffer of CIPN. Therefore, there is a high patient and provider interest in …

Abstract Background/Aim: Chemotherapy-induced peripheral neuropathy (CIPN) is a
common side effect of cancer treatment, resulting in pain, numbness, instability, and thus …